Tuberoinfundibular Dopaminergic Function in Parkinson’s Disease
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 28 (3) , 117-119
- https://doi.org/10.1159/000116245
Abstract
A deficit of nigrostriatal, mesocortical and mesolimbic dopamine systems in Parkinson’s disease is well known. We know less about the involvement of tuberoinfundibular dopamine (TID) systems. In untreated (naive or wash-out) men with Parkinson’s disease, we studied TID function through basal and stimulated plasma levels of growth hormone, prolactin and thyrotropin. Only minor abnormalities in prolactin responses to thyrotropin-releas-ing hormone were found, probably reflecting denervation hypersensitivity. TID function is preserved in men with Parkinson’s disease.Keywords
This publication has 8 references indexed in Scilit:
- Preservation of hypothalamic dopaminergic neurons in Parkinson's diseaseAnnals of Neurology, 1985
- Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's diseaseActa Endocrinologica, 1982
- Growth hormone and prolactin stimulation by Madopar in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1981
- Effect of Levodopa on Thyroid Function and Prolactin ReleaseArchives of Neurology, 1981
- Prolactin secretion in Parkinson diseaseNeurology, 1981
- Twenty-four hour profile of integrated TSH concentration in pubertyJournal of Endocrinological Investigation, 1981
- Abnormal regulation of prolactin release in idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Sinemet® and thyroid function in Parkinson diseaseNeurology, 1979